Clinical Trial: Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament Reconstruction

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07605923) titled 'Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament Reconstruction' on May 18.

Brief Summary: Patients who are being seen for ACL tears will be approached in the UAB Orthopedic Clinic. Included patients will be those aged 14-65 undergoing ACL Reconstruction. Excluded patients will be those with contraindications to corticosteroids. If the patient meets the criteria and agrees to participate, then the consent form will be signed, and the patient will be enrolled. Enrolled patients will be randomized to one of two groups. Patients in the treatment group will receive a 4 mg oral 6-day methylprednisol...